I think we all share a viewpoint the market is under pricing the potential of radiopharmaceuticals in general and Cu6 in particular in the management of metastatic malignant disease. In some ways selling out early to BP deprives us of finding out what could be achieved
- Forums
- ASX - By Stock
- CU6 - ASX Charts
I think we all share a viewpoint the market is under pricing the...
Featured News
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
Add CU6 (ASX) to my watchlist
|
|||||
Last
$5.95 |
Change
0.210(3.66%) |
Mkt cap ! $1.864B |
Open | High | Low | Value | Volume |
$5.95 | $5.99 | $5.76 | $5.971M | 1.017M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 573 | $5.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.96 | 4656 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 573 | 5.930 |
1 | 2500 | 5.900 |
3 | 24907 | 5.850 |
2 | 2665 | 5.840 |
2 | 5656 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
5.960 | 4656 | 1 |
5.970 | 4656 | 2 |
5.990 | 4656 | 1 |
6.000 | 1500 | 1 |
6.010 | 2000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |